Publications by authors named "Siwar AlBashir"

Article Synopsis
  • Early monitoring of adalimumab levels in patients with inflammatory bowel disease (IBD) may help predict clinical outcomes, specifically at week 2 of treatment.
  • A study analyzed the relationship between week 2 serum adalimumab levels and clinical remission by identifying an optimal threshold level of 11.9 mcg/mL.
  • Patients with levels above this threshold showed significantly higher odds of achieving clinical remission by week 12, suggesting that adjusting doses early could be beneficial for those below the threshold.
View Article and Find Full Text PDF

Objectives: To assess the feasibility of a randomized controlled trial (RCT), evaluating the efficacy and patients' perceptions of a psychological intervention aimed at reducing anxiety levels in adults undergoing first-time colonoscopy.

Methods: Adults undergoing first-time colonoscopy were randomized to a psychological intervention vs. sham intervention.

View Article and Find Full Text PDF

This is a case of adult-onset autoimmune enteropathy (AIE) in a 46-year-old man with multiple autoimmune conditions who presented with worsening disease process after receiving cyclophosphamide. We describe the investigations and management of this patient over a 6-year timeline. The diagnosis and management of AIE is challenging given the heterogeneity in clinicopathologic findings and a small number of adult case reports.

View Article and Find Full Text PDF

Importance: There are insufficient data describing the incidence and risk factors of postcolonoscopy complications in older individuals.

Objective: To assess the association between older age (≥75 years) and the risk of postcolonoscopy complications.

Design, Setting, And Participants: This population-based retrospective cohort study included adults (≥50 years) undergoing outpatient colonoscopy between April 2008 and September 2017, identified from Ontario administrative databases.

View Article and Find Full Text PDF

Background: Composite end points are frequently used in reports of clinical trials. One rationale for the use of composite end points is to account for competing risks. In the presence of competing risks, the event rate of a specific event depends on the rates of other competing events.

View Article and Find Full Text PDF

Gastrointestinal (GI) endoscopy is used to inspect the lumen or interior of the GI tract for several purposes, including, (1) making a clinical diagnosis, in real time, based on the visual appearances; (2) taking targeted tissue samples for subsequent histopathological examination; and (3) in some cases, performing therapeutic interventions targeted at specific lesions. GI endoscopy is therefore predicated on the assumption that the operator-the endoscopist-is able to identify and characterize abnormalities or lesions accurately and reproducibly. However, as in other areas of clinical medicine, such as histopathology and radiology, many studies have documented marked interobserver and intraobserver variability in lesion recognition.

View Article and Find Full Text PDF

Endoscopic ultrasonography (EUS) has become a well-accepted test in the workup of acute and chronic pancreatitis. However, further studies are needed to define its diagnostic role in patients with recurrent acute pancreatitis and minimal-change chronic pancreatitis.

View Article and Find Full Text PDF

Objectives: Endoscopic ultrasound (EUS) and hormone-stimulated pancreatic function tests are considered useful, and possibly complementary, in the diagnosis of early chronic pancreatitis (CP). Few past studies have compared either methods with a histological gold standard. The aims were to assess correlations of EUS score and endoscopic pancreatic function test (ePFT) results with the degree of histological fibrosis, as well as the sensitivity of each method for detecting fibrosis.

View Article and Find Full Text PDF

Background & Aims: International consensus guidelines, aimed at predicting malignancy, are available for surgical resection of mucinous cysts but not for other cystic lesions of the pancreas. We sought to determine whether the consensus guidelines can be applied to all cystic lesions of the pancreas.

Methods: We identified all patients who underwent surgical resection of pancreatic cysts from 2001-2007.

View Article and Find Full Text PDF